Please assess the completion status of the following clinical trial:

Trial Title: Impact of Hot Flashes on Sleep and Mood Disturbance

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Women 18-45 years old~* Premenopausal~* Willingness to use barrier methods of contraception during study and after completion of study until menses resume~* Good general health~Exclusion Criteria:~* Pregnancy or currently breastfeeding~* Hot flushes~* Mid-luteal phase progesterone \<3ng/mL~* Clinically significant abnormalities in screening blood tests~* BMI \> 35 kg/m2~* Previously diagnosed osteoporosis or osteopenia~* Clinically significant depressive symptoms~* Psychiatric illness~* Sleep apnea or periodic limb movement of sleep (PLMS)~* Contraindication, hypersensitivity, or previous allergic reaction to GnRH agonists~* Current or recent use of centrally active medications~* Current or recent use of systemic hormone medications~* Night shift workers~* Current use of over-the-counter (OTC) medications that may affect hot flashes, sleep, or mood~* Abnormal vaginal bleeding~* History of any medical diseases that may put subject at risk when treated with study medication.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- GnRH Agonist Injection (Type: EXPERIMENTAL): We will be administering an injection of leuprolide acetate (a GnRH agonist) to all participants.

Based on this trial design, predict the completion outcome and termination type (if applicable).